| Aduro Clean Technologies and AstroTurf Sign MOU for Synthetic Turf Recycling |
Globe Newswire |
06/30 |
08:00 |
| Design Therapeutics Announces Initiation of Patient Dosing in Phase 1 Multiple Ascending Dose Trial of DT-818 for Myotonic Dystrophy Type-1 |
Globe Newswire |
06/30 |
08:00 |
| Sharplink Acquires 10,000 ETH, Bringing Total ETH Holdings to 886,725; Repurchases Over 2.1 Million Shares of Common Stock |
Globe Newswire |
06/30 |
08:00 |
| Quince Therapeutics Appoints Recognized Leaders in Pulmonary Medicine to Scientific Advisory Board |
Globe Newswire |
06/30 |
08:00 |
| MediciNova CEO Provides Shareholder Update |
Globe Newswire |
06/30 |
08:00 |
| Innventure Announces Appointment of Dr. Bill Grieco as CEO following Retirement of Current CEO Bill Haskell |
Globe Newswire |
06/30 |
08:00 |
| KashKick Survey Reveals Mobile Gaming as a Daily Habit and Income Source for Americans |
Globe Newswire |
06/30 |
08:00 |
| U.S. Renal Care and Akebia Announce Interim Analysis of VOICE Trial Demonstrated Overwhelming Statistical Evidence of Improved Safety Outcomes for Patients Treated with Vafseo versus an ESA |
Globe Newswire |
06/30 |
08:00 |
| ALX Oncology Appoints Scott Garland as Chairman of the Board and Michael Listgarten as General Counsel |
Globe Newswire |
06/30 |
08:00 |
| Lands’ End Announces CEO Transition, Positioning Company for Next Phase of Growth |
Globe Newswire |
06/30 |
08:00 |
| Cogent Biosciences Announces Submission of New Drug Application (NDA) for Bezuclastinib in Advanced Systemic Mastocytosis (AdvSM) |
Globe Newswire |
06/30 |
08:00 |
| SCYNEXIS Initiates Phase 1 Study of SCY-770, a Novel AMPK Activator for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD) |
Globe Newswire |
06/30 |
08:00 |
| LB Pharmaceuticals Appoints Christopher Zergebel as Senior Vice President, Clinical Operations |
Globe Newswire |
06/30 |
08:00 |
| Kneat Files Management Information Circular in Connection with the Previously Announced Thoma Bravo Transaction |
Globe Newswire |
06/30 |
07:57 |
| Eos Energy Announces Updated Terms for Rights Offering |
Globe Newswire |
06/30 |
07:50 |
| Eos Announces Pricing of Registered Direct Offering of Common Stock and Warrants to Fund Investment in Frontier Power USA |
Globe Newswire |
06/30 |
07:45 |
| FocalTherics™ Announces Successful Launch of First Commercial Endometriosis Focal One® Program in Europe with Treatment of Initial Patients |
Globe Newswire |
06/30 |
07:30 |
| InflaRx Assessing Feasibility of Broadened Strategy for ANCA‑Associated Vasculitis in Europe Following EMA Recommendation on Tavneos |
Globe Newswire |
06/30 |
07:30 |
| Plus Therapeutics Provides Mid-Year Business Update Including Corporate Rebranding |
Globe Newswire |
06/30 |
07:30 |
| Blockfusion and Blue Acquisition Corp. Announce LOIs for Anchor Lease with a Leading AI Customer and $175 Million Convertible Note Financing and Non-Redemption Agreement, and Advancement of Planned Expansion of Niagara Falls Campus |
Globe Newswire |
06/30 |
07:30 |
| Pacira BioSciences Announces Agreement to Divest its iovera° Business to Zimmer Biomet |
Globe Newswire |
06/30 |
07:30 |
| Pyxis Oncology Announces Up to $114 Million Private Placement Financing to Advance MICVO Through Key Clinical Milestones |
Globe Newswire |
06/30 |
07:30 |
| EPHI Joins UNEP Global Wastewater Initiative to Support Paris Agreement Implementation |
Globe Newswire |
06/30 |
07:30 |
| Edible Garden Announces Letter of Intent for Strategic Commercialization Alliance |
Globe Newswire |
06/30 |
07:27 |
| Bilibili Inc. Provides Update on Share Repurchase Program |
Globe Newswire |
06/30 |
07:10 |
